How Will Philips Acquisition of BioTelemetry Impact The Cardiac Monitoring Market?
Published: February 10, 2021
09th February 2021 – Written by Kelly Patrick – Featured on HIT Consultant – At the end of December 2020, Philips announced the planned acquisition of BioTelemetry for $2.8 billion in cash.
– BioTelemetry was formed in 2013 after a series of acquisitions from the initial founding company CardioNet, Inc.
– CardioNet, Inc. based in San Diego, USA was initially founded in 1994.
– After a multitude of acquisitions in recent years, BioTelemetry has established itself as a leading cardiac powerhouse, specializing in mobile and wireless medical technology. After this rapid acquisition program spanning the last decade, BioTelemetry now has a majority share of the remote cardiac monitoring market.
Click here to continue reading on HIT Consultant’s website…Share on LinkedIn
Clinical Care DevicesPublished March 2021
Clinical Care Devices
This is Signify Research’s 2021 report on the Clinical Care Devices Market, which was published in March 2021.
Find out more